Viewing Study NCT06789757


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-30 @ 11:52 PM
Study NCT ID: NCT06789757
Status: RECRUITING
Last Update Posted: 2025-10-07
First Post: 2024-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
Sponsor: Inova Health Care Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module